Dr Kimberly Rockley Presents at the 2019 Gordon Research Conference

Kim Rockley Presenting at GRC

Dr Kimberly Rockley and Professor Ruth Roberts had a fabulous time at the Gordon Research Seminar (GRS) and Conference (GRC) earlier this month.  GRCs provide an international forum for the presentation and discussion of cutting-edge research in science; GRSs are organised by and for young investigators and take place alongside the GRC.

Kim Rockley and EUROTOX winners at GRS

L to R Heather Wallace, Kim Rockley, Luca Dellafiora, Steven Kunnen, Madalena Cipriano, Rhianna Hardwick and Ruth Roberts



Originally, Kim received a EUROTOX Fellowship Grant to attend the GRC/GRS together with 3 other early career investigators, Dr Madalena Cipriano, Dr Steven Kunnen and Dr Luca Dellafiora.






Kim Rockley and Cassandra Meakin

Kim Rockley and Cassandra Meakin

Kim’s poster abstract entitled ‘In Vitro Evaluation of Anthracycline-Induced Induced Cardiotoxicity and Mitigation by Angiotensin Blockade’ was initially selected for presentation at the GRS on Sunday but then Kim was thrilled to win the “Best Post Doc Talk” prize leading to a presentation slot on the podium at the main GRC!  Alongside Kim, Cassandra Meakin won the “Best PhD Talk” and also went on to present in the main GRC.


Kim commented “I really enjoyed the GRS and GRC and was very pleased that my talk was selected for the best post doc talk prize! The GRS was an excellent opportunity to network with other early career researchers in a relaxed environment and learn about their work. It was exciting to learn about all the different types of research within toxicology and I hope to go again to the next GRC/GRS in 2021.”

Past, Present and Future GRC and GRS Chairs

L to R Kari Sant Echevarria, Ruth Roberts, Jose Manautou, Heather Wallace, Rhiannon Hardwick, Alessandro Venosa, John Richburg, Ron Hines, Cassandra Meakin, Phillip Wages, Charlene McQueen, Emma Bowers, Katelyn Lavrich and Enrique Fuentes-Mattei


Ruth presented a poster on Evaluation of the Toxicological Risk of targeting FRS (Phenylalanyl tRNA Synthetase) in the Treatment of Malaria which highlighted the value of target safety assessments, especially early in drug projects.  “It was great to catch up with past, present and future chairs of the Gordon Research Conference and wonderful to hear that Professor Heather Wallace, current President of EUROTOX, has become Vice Chair Elect in 2021 and Chair Elect in 2023”, added Ruth.